Nektar TherapeuticsNKTRNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Trending higher, below historical average, structural decline.
Left:
||||
Enterprise value to sales ratio
Latest
2.54
↓ 83% below average
Average (9y)
14.84
Historical baseline
Range
High:35.68
Low:2.11
CAGR
-14.6%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 2.54 | +20.3% |
| 2023 | 2.11 | -58.4% |
| 2022 | 5.06 | -80.1% |
| 2021 | 25.46 | +30.3% |
| 2020 | 19.54 | -45.3% |
| 2019 | 35.68 | +612.9% |
| 2018 | 5.00 | -83.9% |
| 2017 | 31.05 | +170.1% |
| 2016 | 11.49 | +9.4% |
| 2015 | 10.50 | - |